Maybe you saw someone mention semaglutide heart palpitations or semaglutide heart rate variability. Its normal to have questions, especially when it comes to your heart health
Full therapeutic effects for weight management should be evaluated after 12 weeks at a maintenance dose (typically 10-15 mg weekly), while glycemic response for diabetes is assessed after 3-6 months on a stable dose
Services vary by location
Together, these actions help prevent spikes in blood sugar
The FDA provides specific guidelines based on estimated glomerular filtration rate (eGFR): Strictly prohibited for patients with eGFR below 30 mL/minute/1.73 m Not recommended for starting treatment in patients with eGFR between 30-45 mL/minute/1.73 m Requires careful monitoring when eGFR falls below 45 mL/minute/1.73 m Patients should avoid metformin if they have: Diabetic ketoacidosis Severe liver problems Acute or chronic metabolic acidosis History of lactic acidosis Conditions causing tissue hypoxia The medication is not recommended for patients 80 and older without normal kidney function [22]
Gathering patient information Collect essential patient data, including weight, height, and gender
